Aug 13, 2020 / 01:00PM GMT
Heikki Lanckriet - 4basebio AG - CEO, Chief Scientific Officer & Member of Management Board
Thank you very much, Haley, and good afternoon, everybody, and thanks for joining us on the H1 update call. As always, I have to start with the usual disclaimer so I'll just give you a few moments to familiarize yourself as the slide move forward.
Okay, thank you. All right. I guess, not a huge amount has changed since the AGM in late June, so to some extent, today I'll reiterate on some of the points made then. And there's a few updates here and there as well, so you'll note that we continue to make good progress. And then at the back end of the presentation, David will provide some more insights on the H1 financials. Again, not a huge amount of surprises there as everything is pretty much developing in line to our expectations and in line of what we've communicated previously.
Anyway, so we'll start off with the company overview. So for those of you who are joining us for the first time, because I did notice a few new names on the list, today on the call, we've got David, our CFO. You can
Half Year 2020 4Basebio AG Earnings Call Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers